Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | F7 | P08709 | 3/20 | 0.45 |
| ▸ | F3 | P13726 | 3/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15726990 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL21052411 | 0.90 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL21052413 | 0.90 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL3688338 | 0.89 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL3688336 | 0.89 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL20086311 | 0.86 | ALDH1A1 (0.47) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL20086306 | 0.86 | ALDH1A1 (0.50) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL20086304 | 0.86 | ALDH1A1 (0.46) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL23520453 | 0.85 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| Icosabutate SCHEMBL21585131 | 0.85 | ALDH1A1 (0.51) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8735436-B2 | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-05-27 | — | — | US | claimed |
| US-12599580-B2 | Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | BASF AS (NO) | 2026-04-14 | — | — | US | disclosed |
| US-20240325336-A1 | COMBINATION THERAPIES COMPRISING OXYGEN-CONTAINING STRUCTURALLY ENHANCED FATTY ACIDS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | NORTHSEA THERAPEUTICS B.V. (NL) | 2024-10-03 | — | — | US | disclosed |
| US-20230090432-A1 | COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | PRONOVA BIOPHARMA NORGE AS (NO) | 2023-03-23 | — | — | US | disclosed |
| US-11351139-B2 | Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | BASF AS (NO) | 2022-06-07 | — | — | US | disclosed |
| US-20210177794-A1 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2021-06-17 | — | — | US | disclosed |
| CN-105120842-B | Compositions comprising lipid compounds, triglycerides and surfactants and methods of using the same | 普罗诺瓦生物医药挪威公司 | 2020-12-01 | — | — | CN | disclosed |
| EP-3720431-A1 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2020-10-14 | — | — | EP | disclosed |
| CN-111712240-A | Fatty acid derivatives for the treatment of non-alcoholic steatohepatitis | 巴斯夫股份公司 | 2020-09-25 | — | — | CN | disclosed |
| EP-3578170-A1 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | BASF AS (NO) | 2019-12-11 | — | — | EP | disclosed |
| EP-2961384-B1 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | BASF AS (NO) | 2019-08-28 | — | — | EP | disclosed |
| EP-2961384-B1 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | BASF AS (NO) | 2019-08-28 | — | — | EP | disclosed |
| WO-2019111048-A1 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | BASF AS (NO) | 2019-06-13 | — | — | WO | disclosed |
| US-20180110747-A1 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | BASF AS (NO) | 2018-04-26 | — | — | US | disclosed |
| US-20180110747-A1 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | BASF AS (NO) | 2018-04-26 | — | — | US | disclosed |
| US-20160206585-A1 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | BASF AS (NO) | 2016-07-21 | — | — | US | disclosed |
| US-8735436-B2 | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-05-27 | — | — | US | disclosed |
| US-8735436-B2 | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-05-27 | — | — | US | disclosed |
| WO-2010128401-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210177794-A1 | FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | CPT1A, NR1H3, NR1H2 | ALDH1A1 162/4885CYP3A4 796/4885ALOX15 65/4885 |
| US-11351139-B2 | Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | LIPA, SCD5, SBDS | ALDH1A1 1748/4885CYP3A4 864/4885ALOX15 10/4885 |
| US-20240325336-A1 | COMBINATION THERAPIES COMPRISING OXYGEN-CONTAINING STRUCTURALLY ENHANCED FATTY ACIDS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | ACACA, PC, ACACB | ALDH1A1 525/4885CYP3A4 1003/4885ALOX15 176/4885 |
| US-12599580-B2 | Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | LIPA, LIPC, LIPG | ALDH1A1 3488/4885CYP3A4 2293/4885ALOX15 32/4885 |
| US-20230090432-A1 | COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | LIPA, SCD5, SBDS | ALDH1A1 1748/4885CYP3A4 864/4885ALOX15 10/4885 |
| US-20180110747-A1 | USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3 | APOB, TTPA, APOL1 | ALDH1A1 2466/4885CYP3A4 735/4885ALOX15 80/4885 |
| US-20160206585-A1 | A COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME | SCD5, LIPA, SBDS | ALDH1A1 1492/4885CYP3A4 653/4885ALOX15 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.